Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials
- PMID: 25559848
- PMCID: PMC4283966
- DOI: 10.1371/journal.pone.0116207
Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials
Abstract
Objective: To investigate whether compliance of patients to antibiotic treatment is better when antibiotics are administered once than multiple times daily.
Methods: We performed a systematic search in PubMed and Scopus databases. Only randomized controlled trials were considered eligible for inclusion. Compliance to antibiotic treatment was the outcome of the meta-analysis.
Results: Twenty-six studies including 8246 patients with upper respiratory tract infections in the vast majority met the inclusion criteria. In total, higher compliance was found among patients treated with once-daily treatment than those receiving treatment twice, thrice or four times daily [5011 patients, RR=1.22 (95% CI, 1.11, 1.34]. Adults receiving an antibiotic once-daily were more compliant than those receiving the same antibiotic multiple times daily [380 patients, RR=1.09 (95% CI, 1.02, 1.16)]. Likewise, children that received an antibiotic twice-daily were more compliant than those receiving the same antibiotic thrice-daily [2118 patients, RR=1.10 (95% CI, 1.02, 1.19)]. Higher compliance was also found among patients receiving an antibiotic once compared to those receiving an antibiotic of different class thrice or four times daily [395 patients, RR=1.20 (95% CI, 1.12, 1.28)]. The finding of better compliance with lower frequency daily was consistent regardless of the study design, and treatment duration.
Conclusion: This meta-analysis showed that compliance to antibiotic treatment might be associated with higher when an antibiotic is administered once than multiple times daily for the treatment of specific infections and for specific classes of antibiotics.
Conflict of interest statement
Figures







Similar articles
-
The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance.J Antimicrob Chemother. 2009 Feb;63(2):396-9. doi: 10.1093/jac/dkn472. Epub 2008 Nov 16. J Antimicrob Chemother. 2009. PMID: 19015142
-
Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial.J Antimicrob Chemother. 2007 Mar;59(3):531-6. doi: 10.1093/jac/dkl528. Epub 2007 Feb 8. J Antimicrob Chemother. 2007. PMID: 17289766 Clinical Trial.
-
[Patient compliance in the treatment of respiratory tract infections].Lijec Vjesn. 1997 Jul;119(7):193-200. Lijec Vjesn. 1997. PMID: 9471478 Croatian.
-
Patient compliance with antibiotic treatment for respiratory tract infections.J Antimicrob Chemother. 2002 Jun;49(6):897-903. doi: 10.1093/jac/dkf046. J Antimicrob Chemother. 2002. PMID: 12039881 Review.
-
Selective oropharyngeal decontamination versus selective digestive decontamination in critically ill patients: a meta-analysis of randomized controlled trials.Drug Des Devel Ther. 2015 Jul 14;9:3617-24. doi: 10.2147/DDDT.S84587. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26203227 Free PMC article. Review.
Cited by
-
A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship.Antimicrob Steward Healthc Epidemiol. 2022 Jan 31;2(1):e17. doi: 10.1017/ash.2021.252. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36310801 Free PMC article. No abstract available.
-
Clinically important interactions of macrolides and tetracyclines with dietary interventions-a systematic review with meta-analyses.J Antimicrob Chemother. 2024 Nov 4;79(11):2762-2791. doi: 10.1093/jac/dkae315. J Antimicrob Chemother. 2024. PMID: 39254058 Free PMC article.
-
Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?Respir Res. 2019 Aug 2;20(1):173. doi: 10.1186/s12931-019-1127-6. Respir Res. 2019. PMID: 31375102 Free PMC article.
-
Systemic Azithromycin as an Adjunct to Non-Surgical Subgingival Instrumentation in the Treatment of Stage III/IV, Grade C Periodontitis: 12-Month Clinical, Microbiological and Cytokine Results of a Randomised Controlled Trial.J Clin Periodontol. 2025 May;52(5):666-680. doi: 10.1111/jcpe.14150. Epub 2025 Mar 24. J Clin Periodontol. 2025. PMID: 40123306 Free PMC article. Clinical Trial.
-
Advancements in Aerogel Technology for Antimicrobial Therapy: A Review.Nanomaterials (Basel). 2024 Jun 28;14(13):1110. doi: 10.3390/nano14131110. Nanomaterials (Basel). 2024. PMID: 38998715 Free PMC article. Review.
References
-
- Samonis G, Koutsounaki E, Karageorgopoulos DE, Mitsikostas P, Kalpadaki C, et al. (2012) Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. Eur J Clin Microbiol Infect Dis 31: 1389–1398. 10.1007/s10096-011-1454-0 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous